GeoVax is seeking an offering through the SEC, with Roth Capital Partners serving as the exclusive placement agent.
1 report, 0 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GeoVax is seeking an offering through the SEC, with Roth Capital Partners serving as the exclusive placement agent.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GeoVax
biotechnology company
Nothing else this week.
-
ROTH Capital Partners
American small privately held investment banking company
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
-
Securities and Exchange Commission
government agency of the Philippines
- A bill allowing foreign investment in cooperatives has been approved, concerning legitimate organizations registered with the Securities and Exchange Commission.
- Vanguard Short-Term Inflation-Protected Securities ETF is disclosing its holdings to the SEC and trading on the Nasdaq electronic stock exchange.
Related events
- The SEC declared a registration statement effective for a company, which trades securities on the NASDAQ Global Market.
- Evolution Petroleum Corporation, Inc. filed an offering with the SEC, with ROTH Capital Partners serving as the sole book-running manager. The bookrunner's office is located in Newport Beach.
- Veradermics, Incorporated disclosed company filings with the Securities and Exchange Commission on August 18, 2026.
- Vaxcyte, Inc. filed required documents with the SEC and traded on the NASDAQ exchange.
- BioLineRx Ltd. is utilizing the Nasdaq stock exchange for a registered direct offering, filing with the SEC.
Coverage
Newest first; wire copies grouped- Unknown outlet